As of Jul 19
| -0.15 / -1.13%|
The 6 analysts offering 12-month price forecasts for Protagonist Therapeutics Inc have a median target of 17.50, with a high estimate of 29.00 and a low estimate of 17.00. The median estimate represents a +33.18% increase from the last price of 13.14.
The current consensus among 6 polled investment analysts is to Buy stock in Protagonist Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.